arrow_back Back to App

Rare Disease Day: Raising Awareness and Supporting Research

The U.S. Senate designated February 28, 2022, as Rare Disease Day. This aims to increase public awareness of these conditions, which affect millions of Americans, and emphasize the need for further research and effective treatments. Citizens with rare diseases and their families can expect greater support in accessing diagnosis and treatment.
Key points
The designation of Rare Disease Day aims to highlight the challenges faced by individuals with these conditions, including difficulties in diagnosis and limited access to treatment.
It emphasizes the importance of accurate and early diagnosis and supporting national and global efforts to develop effective treatments and diagnostics.
The resolution acknowledges progress in rare disease research, stemming from previous acts like the Orphan Drug Act, offering hope for new therapies for patients.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_523
Sponsor: Sen. Brown, Sherrod [D-OH]
Process start date: 2022-02-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating February 28, 2022, as "Rare Disease Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_523.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-02-17.

What are the main provisions?

Key points include:

  • The designation of Rare Disease Day aims to highlight the challenges faced by individuals with these conditions, including difficulties in diagnosis and limited access to treatment.
  • It emphasizes the importance of accurate and early diagnosis and supporting national and global efforts to develop effective treatments and diagnostics.
  • The resolution acknowledges progress in rare disease research, stemming from previous acts like the Orphan Drug Act, offering hope for new therapies for patients.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Brown, Sherrod [D-OH].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S800; text: CR S793-794)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health